drug

BS-001

Phase 2updated 3mo ago

by Wuhan Binhui Biopharmaceutical Co Ltd

Phase 2

community read0 votes

indications

Melanoma

all catalysts(0)

nothing on the calendar yet

Trials studying BS-001

N/AA 14-week Pilot Prospective Clinical Trial With BiOkuris Product in Patients With Irritable Bowel Syndromecompletedn=116
phase3A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degenerationnot yet recruitingn=434

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 21m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

BS-001

Phase 2updated 3mo ago

by Wuhan Binhui Biopharmaceutical Co Ltd

Phase 2

community read0 votes

indications

Melanoma

all catalysts(0)

nothing on the calendar yet

Trials studying BS-001

N/AA 14-week Pilot Prospective Clinical Trial With BiOkuris Product in Patients With Irritable Bowel Syndromecompletedn=116
phase3A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degenerationnot yet recruitingn=434

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 21m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

BS-001

indications

all catalysts(0)

Trials studying BS-001

News(0)

Report a data issue

comments(0)

BS-001

indications

all catalysts(0)

Trials studying BS-001

News(0)

Report a data issue

comments(0)